Rays Diagno Interventions Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 09-12-2024
- Paid Up Capital ₹ 1.00 M
as on 09-12-2024
- Company Age 8 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.94 Cr
as on 09-12-2024
- Revenue 67.86%
(FY 2023)
- Profit -75.91%
(FY 2023)
- Ebitda 87.88%
(FY 2023)
- Net Worth 7.34%
(FY 2023)
- Total Assets 18.93%
(FY 2023)
About Rays Diagno Interventions
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹7.94 Cr.
Anubha Pandey, Apurv Sharma, Meena Sharma, and One other member serve as directors at the Company.
- CIN/LLPIN
U74999UP2016PTC086366
- Company No.
086366
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Sep 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Varanasi, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Rays Diagno Interventions?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Apurv Sharma  | Director | 14-Sep-2016 | Current |
| Anubha Pandey | Director | 14-Sep-2016 | Current |
| Meena Sharma | Director | 14-Sep-2016 | Current |
| Ram Sharma | Director | 08-May-2018 | Current |
Financial Performance of Rays Diagno Interventions.
Rays Diagno Interventions Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 67.86% increase. The company also saw a substantial fall in profitability, with a 75.91% decrease in profit. The company's net worth moved up by a moderate rise of 7.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rays Diagno Interventions?
Unlock access to Rays Diagno Interventions's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 13 Mar 2024 | ₹1.71 Cr | Open |
Others Creation Date: 25 Jan 2024 | ₹3.10 M | Open |
Others Creation Date: 08 Mar 2022 | ₹3.20 Cr | Open |
How Many Employees Work at Rays Diagno Interventions?
Unlock and access historical data on people associated with Rays Diagno Interventions, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rays Diagno Interventions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rays Diagno Interventions's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
